Marginal-zone lymphomas
Marginal-Zone Lymphomas The third most common lymphoma, MZL is usually indolent and
often a consequence of chronic antigenic stimulation from a pathogen such as Helicobacter …
often a consequence of chronic antigenic stimulation from a pathogen such as Helicobacter …
Challenges in clinical development of mesenchymal stromal/stem cells: concise review
I Mastrolia, EM Foppiani, A Murgia… - Stem cells …, 2019 - academic.oup.com
Identified 50 years ago, mesenchymal stromal/stem cells (MSCs) immediately generated a
substantial interest among the scientific community because of their differentiation plasticity …
substantial interest among the scientific community because of their differentiation plasticity …
Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up✰
E Zucca, L Arcaini, C Buske, PW Johnson… - Annals of …, 2020 - annalsofoncology.org
In the last update of the World Health Organization (WHO) classification, the marginal zone
B-cell lymphomas (MZLs) comprise extranodal MZL (EMZL) of mucosa-associated lymphoid …
B-cell lymphomas (MZLs) comprise extranodal MZL (EMZL) of mucosa-associated lymphoid …
Cryoglobulinaemia
D Roccatello, D Saadoun, M Ramos-Casals… - Nature Reviews …, 2018 - nature.com
Cryoglobulinaemia refers to the serum presence of cryoglobulins, which are defined as
immunoglobulins that precipitate at temperatures< 37° C. Type I cryoglobulinaemia consists …
immunoglobulins that precipitate at temperatures< 37° C. Type I cryoglobulinaemia consists …
Durable ibrutinib responses in relapsed/refractory marginal zone lymphoma: long-term follow-up and biomarker analysis
A Noy, S de Vos, M Coleman, P Martin… - Blood …, 2020 - ashpublications.org
Advanced marginal zone lymphoma (MZL) is an incurable B-cell malignancy dependent on
B-cell receptor signaling. The phase 2 PCYC-1121 study demonstrated the safety and …
B-cell receptor signaling. The phase 2 PCYC-1121 study demonstrated the safety and …
[HTML][HTML] Marginal zone lymphoma: present status and future perspectives
Marginal zone lymphomas (MZL) are collectively the second most common indolent
lymphoma comprising 7% of all non-Hodgkin lymphomas with 7,460 patients diagnosed in …
lymphoma comprising 7% of all non-Hodgkin lymphomas with 7,460 patients diagnosed in …
[HTML][HTML] International therapeutic guidelines for patients with HCV-related extrahepatic disorders. A multidisciplinary expert statement
Hepatitis C virus (HCV) is both hepatotrophic and lymphotropic virus that causes liver as
well extrahepatic manifestations including cryoglobulinemic vasculitis, the most frequent and …
well extrahepatic manifestations including cryoglobulinemic vasculitis, the most frequent and …
[HTML][HTML] NOTCH1 aberrations in chronic lymphocytic leukemia
E Rosati, S Baldoni, F De Falco, B Del Papa… - Frontiers in …, 2018 - frontiersin.org
Chronic lymphocytic leukemia (CLL) is an incurable B-cell neoplasm characterized by highly
variable clinical outcomes. In recent years, genomic and molecular studies revealed a …
variable clinical outcomes. In recent years, genomic and molecular studies revealed a …
[PDF][PDF] Efficacy and safety of new direct antiviral agents in hepatitis C virus–infected patients with diffuse large B‐cell non‐Hodgkin's lymphoma
The association of hepatitis C virus (HCV) with non‐Hodgkin's lymphoma (NHL) has been
demonstrated throughout the world. The new interferon‐free direct antiviral agents (DAAs) …
demonstrated throughout the world. The new interferon‐free direct antiviral agents (DAAs) …
[HTML][HTML] The NOTCH pathway and its mutations in mature B cell malignancies
F Arruga, T Vaisitti, S Deaglio - Frontiers in oncology, 2018 - frontiersin.org
The systematic application of next-generation sequencing to large cohorts of oncologic
samples has opened a Pandora's box full of known and novel genetic lesions implicated in …
samples has opened a Pandora's box full of known and novel genetic lesions implicated in …